Spontaneous Clostridium perfringens myonecrosis of the shoulder: A case report

Clinical Orthopaedics and Related Research

Volumn 461, Issue , 2007, Pages 20-24

  Lanting, Brent ^a   Athwal, George S ^b   Naudie, Douglas D R ^c  

^a WESTERN UNIVERSITY   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CLINDAMYCIN; METRONIDAZOLE; PENICILLIN G;

ADULT; ANTIBIOTIC THERAPY; BACTERIAL GROWTH; BACTERIUM CULTURE; CASE REPORT; CLOSTRIDIUM PERFRINGENS; CONFERENCE PAPER; DEBRIDEMENT; DISEASE COURSE; GAS GANGRENE; HUMAN; MALE; PRIORITY JOURNAL; SCAPULA; SHOULDER; SHOULDER PAIN; SUBCUTANEOUS EMPHYSEMA; TREATMENT OUTCOME; ARTICLE; MICROBIOLOGY; NECROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; RADIOGRAPHY; SKELETAL MUSCLE;

ADULT; CLOSTRIDIUM PERFRINGENS; DEBRIDEMENT; DISEASE PROGRESSION; GAS GANGRENE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MUSCLE, SKELETAL; NECROSIS; SHOULDER; SUBCUTANEOUS EMPHYSEMA;

EID: 34548314609     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/BLO.0b013e318073c273     Document Type: Conference Paper

References (24)

1. Abella BS, Kuchinic P, Hiraoka T, Howes DS. Atraumatic clostridial myonecrosis: case report and literature review. J Emerg Med. 2003;24:401-405.
2. Barza M, Pins M. Case 5-1993: an 81 year old man with pain and crepitus in the shoulder. N Engl J Med. 1993;328:340-346.
3. Bryant AE, Chen RY, Nagata Y, Wang Y, Lee CH, Finegold S, Guth PH, Stevens DL. Clostridial gas gangrene: I: Cellular and molecular mechanisms of microvascular dysfunction induced by exotoxins of Clostridium perfringens. J Infect Dis. 2000;182:799-807.
4. Bryant AE, Chen RY, Nagata Y, Wang Y, Lee CH, Finegold S, Guth PH, Stevens DL. Clostridial gas gangrene: II: Phospholipase C-induced activation of platelet gpIIbIIIa medicates vascular occlusion and myonecrosis in Clostridium perfringens gas gangrene. J Infect Dis. 2000;182:808-815.
5. Bullifent HL, Moir A, Awad M, Scott P, Rood J, Titball RW. The level of expression of alpha-toxin by different strains of Clostridium perfringens is dependent on differences in promoter structure and genetic background. Anaerobe. 1996;2:365-371.
6. Bunting M, Lorant DE, Bryant AE, Zimmerman GA, McIntyre TM, Stevens DL, Prescott SM. Alpha toxin from Clostridium perfringens induces proinflammatory changes in endothelial cells. J Clin Invest. 1997;100:565-574.
7. Burke MP, Opeskin K. Nontraumatic clostridial myonecrosis. Am J Forensic Med Pathol. 1999;20:158-162.
8. Flores-Diaz M, Alape-Giron A. Role of Clostridium perfringens phospholipase C in the pathogenesis of gas gangrene. Toxicon. 2003;42:979-986.
9. Garcia-Suarez J, de Miguel D, Krsnik I, Barr-Ali M, Hernanz N, Burgaleta C. Spontaneous gas gangrene in malignant lymphoma: an underreported complication? Am J Hematol. 2002;70:145-148.
10. Goon PK, O'Brien M, Titley OG. Spontaneous Clostridium septicum septic arthritis of the shoulder and gas gangrene: a case report. J Bone Joint Surg Am. 2005;87:874-877.
11. Hausmann R, Albert F, Geissdorfer W, Betz P. Clostridium fallax associated with sudden death in a 16-year-old boy. J Med Microbiol. 2004;53:581-583.
12. Jacob ZC, Dedekian M, Seoudi H. Nontraumatic clostridial myonecrosis: an indication for colonoscopy? Am Surg. 2002;68:463-465.
13. Kasper D, Madoff L, eds. Harrison's Online: Principles of Internal Medicine. Chapter 126. Available at: http://www.accessmedicine.com.proxy2. lib.uwo.ca:2048/content.aspx?aID=70096. Accessed Arpil 29, 2007.
14. Kornbluth AA, Danzig JB, Bernstein LH. Clostridium septicum infection and associated malignancy: report of 2 cases and review of the literature. Medicine (Baltimore). 1989;68:30-37.
15. Kuroda S, Okada Y, Mita M, Okamoto Y, Hato H, Ueyama S, Fujii I, Morita S, Yoshida Y. Fulminant massive gas gangrene caused by Clostridium perfringens. Intern Med. 2005;44:499-502.
16. Larson CM, Bubrick MP, Jacobs DM, West MA. Malignancy, mortality, and medicosurgical management of Clostridium septicum infection. Surgery. 1995;118:592-597.
17. Nordkild P, Crone P. Spontaneous clostridial myonecrosis: a collective review and report of a case. Ann Chir Gynaecol. 1986;75:274-279.
18. O'Brien DK, Melville SB. Effects of Clostridium perfringens alphatoxin (PLC) and perfringolysin O (PFO) on cytotoxicity to macrophages, on escape from the phagosomes of macrophages, and on persistence of C. perfringens in host tissues. Infect Immun. 2004;72:5204-5215.
19. Smith LV, Holdeman LD. Clostridium perfringens. In: The Pathogenic Anaerobic Bacteria. Springfield, IL: Charles C. Thomas; 1968:201-255.
20. Stephens MB. Gas gangrene: potential for hyperbaric oxygen therapy. Postgrad Med. 1996;99:217-224.
21. Stevens DL, Bryant AE. The role of clostridial toxins in the pathogenesis of gas gangrene. Clin Infect Dis. 2002;35(suppl 1):S93-S100.
22. Stevens DL, Maier KA, Laine BM, Mitten JE. Comparison of clindamycin, rifampin, tetracycline, metronidazole, and penicillin for efficacy in prevention of experimental gas gangrene due to Clostridium perfringens. J Infect Dis. 1987;155:220-228.
23. Stevens DL, Maier KA, Mitten JE. Effect of antibiotics on toxin production and viability of Clostridium perfringens. Antimicrob Agents Chemother. 1987;31:213-218.
24. Zelic M, Vukas D, Vukas D Jr, Valkovic P, Kovac D, Sustic A, Rukavina T. Fulminant endogene gas gangrene in a previously healthy male. Scand J Infect Dis. 2004;36:388-389.